Regeneron Pharmaceuticals’ Inmazeb FDA approval: A milestone in Ebola treatment

pharmanewsdaily- October 15, 2020 0

Regeneron Pharmaceuticals has achieved a significant breakthrough with the approval of its antibody cocktail, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), by the U.S. Food and Drug ... Read More